Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
Objectives The standard first-line treatment for Helicobacter pylori infection typically involves proton pump inhibitors, amoxicillin, and clarithromycin (PAC), yet the eradication success rates are not entirely satisfactory. Recognizing bismuth’s antibacterial properties and its potential to enhanc...
Saved in:
Main Authors: | Seon Woo Oh, Keun Sol Min, Hyung Geun Kim, Sunmi Lee, Chul-Hyun Lim, Jung-Hwan Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2025-03-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://helicojournal.org/upload/pdf/kjhugr-2024-0077.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance
by: Yun Duk Jung, et al.
Published: (2017-12-01) -
Comparison of bismuth and concomitant therapy for H. pylori eradication: a prospective, randomized clinical trial
by: A. Oueslati, et al.
Published: (2025-12-01) -
Detection of Clarithromycin Resistance in Helicobacter pylori Using the AllplexTM H. pylori & ClariR Assay and the Ezplex® HP-CLA Real-Time PCR Kit
by: Tae-Woo Kim, et al.
Published: (2025-03-01) -
Eradication of Helicobacter pylori Infection Using 7-day PCR-based Tailored Therapy
by: Youngwoo Kim, et al.
Published: (2023-06-01) -
Comparing Two Treatment Regimens for Helicobacter pylori Eradication: Furazolidone or Clarithromycin?
by: Shirin Rezaei, et al.
Published: (2025-07-01)